These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 9380549)
41. Playing with evolution requires planning. Richman DD; Lange JM Antivir Ther; 1996 Dec; 1(4):208-9. PubMed ID: 11324822 [No Abstract] [Full Text] [Related]
42. Doctors call for specialized HIV/AIDS treatment for children. AIDS Policy Law; 2004 Nov; 19(21):5. PubMed ID: 15614952 [No Abstract] [Full Text] [Related]
43. Clinical data marshalled to treat HIV. Clarke T Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390 [No Abstract] [Full Text] [Related]
44. Easy does it. Over the course of 20 years, the treatment of HIV infection has changed dramatically. Rodriguez E Posit Living; 2002; 11(3):13-4. PubMed ID: 12035756 [No Abstract] [Full Text] [Related]
45. Pediatric compliance in combination HIV therapy. Getting it right the first time. Moloney C; Damon B; Regan AM Adv Nurse Pract; 1998 Mar; 6(3):35-8. PubMed ID: 9582738 [No Abstract] [Full Text] [Related]
46. New guidelines provide greater flexibility in treating HIV. Strain W Posit Living; 1999 Jun; 8(5):6, 16. PubMed ID: 12492069 [No Abstract] [Full Text] [Related]
47. A guide to using this guide. Berry J Posit Aware; 2006; 17(1):9. PubMed ID: 16475267 [No Abstract] [Full Text] [Related]
48. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient. Tachikawa N; Yasuoka A; Oka S Jpn J Infect Dis; 1999 Dec; 52(6):245-6. PubMed ID: 10738363 [No Abstract] [Full Text] [Related]
49. Ethics in action. Haddad A RN; 1998 Mar; 61(3):21-4. PubMed ID: 9544088 [No Abstract] [Full Text] [Related]
50. Multidrug maestro: 20 years on the trail of HIV. An interview with Martin S. Hirsch. Interview by Mark Mascolini. Hirsch MS IAPAC Mon; 2001 Apr; 7(4):104-9, 113. PubMed ID: 11700604 [No Abstract] [Full Text] [Related]
51. A kinder, gentler approach to treatment. Interview by Paul Simmons. Mauss S Res Initiat Treat Action; 1998 Aug; 4(5):3-5. PubMed ID: 11365708 [TBL] [Abstract][Full Text] [Related]
52. Intent-to-treat analysis. Kravcik S HIV Clin Trials; 2003; 4(6):425. PubMed ID: 14677539 [No Abstract] [Full Text] [Related]
54. Behind the frontline. A doctor looks at combos & side effects. Vázquez E Posit Aware; 2003; 14(1):63-4. PubMed ID: 12630377 [No Abstract] [Full Text] [Related]
55. CASTLE data show no gender differences. AIDS Patient Care STDS; 2008 Sep; 22(9):762. PubMed ID: 18802980 [No Abstract] [Full Text] [Related]
59. Mix and match. With as many as six drug categories, more than ever, how to treat HIV can become a matter of strategy. Gallant J Posit Aware; 2010; 21(2):18-9. PubMed ID: 20524347 [No Abstract] [Full Text] [Related]
60. [Quality of life as the focus of modern anti-HIV treatment. More compact regimens for therapy success]. MMW Fortschr Med; 2001 Sep; 143(35-36):58-9. PubMed ID: 11584536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]